EVOLUS, INC. Share-based Payment Arrangement, Amount Capitalized
EVOLUS, INC. (EOLS) reported Share-based Payment Arrangement, Amount Capitalized of $15.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-08-05
- EVOLUS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2026-06-30 was $15.00K, a 57.14% decline year-over-year.
- EVOLUS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $5.00K, a 86.84% decline year-over-year.
- EVOLUS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $11.00K, a 38.89% decline year-over-year.
- EVOLUS, INC. share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $14.00K, a 44.00% decline year-over-year.
- EVOLUS, INC. share-based payment arrangement, amount capitalized for fiscal 2025 was $98.00K, a 48.48% increase from fiscal 2024.
- EVOLUS, INC. share-based payment arrangement, amount capitalized for fiscal 2024 was $66.00K.
- EVOLUS, INC. share-based payment arrangement, amount capitalized for fiscal 2023 was $0.00.
| Period end | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month | Share-based Payment Arrangement, Amount Capitalized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $15.00K 10-Q · filed 2026-08-05 | $20.00K 10-Q · filed 2026-08-05 | $31.00K derived: sum of 3 quarters · filed 2026-08-05 | $45.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-04 | $16.00K derived: sum of 2 quarters · filed 2026-05-04 | $30.00K derived: sum of 3 quarters · filed 2026-05-04 | $65.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $25.00K derived: sum of 2 quarters · filed 2026-03-03 | $60.00K derived: sum of 3 quarters · filed 2026-08-05 | $98.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $14.00K 10-Q · filed 2025-11-05 | $49.00K derived: sum of 2 quarters · filed 2026-08-05 | $87.00K 10-Q · filed 2025-11-05 | $105.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $35.00K 10-Q · filed 2026-08-05 | $73.00K 10-Q · filed 2026-08-05 | $91.00K derived: sum of 3 quarters · filed 2026-08-05 | $116.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $38.00K 10-Q · filed 2026-05-04 | $56.00K derived: sum of 2 quarters · filed 2026-05-04 | $81.00K derived: sum of 3 quarters · filed 2026-05-04 | $91.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $43.00K derived: sum of 2 quarters · filed 2026-03-03 | $53.00K derived: sum of 3 quarters · filed 2026-03-03 | $66.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $25.00K 10-Q · filed 2025-11-05 | $35.00K derived: sum of 2 quarters · filed 2025-11-05 | $48.00K 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $10.00K 10-Q · filed 2025-08-05 | $22.00K 10-Q · filed 2025-08-05 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |